Skip to main content
Top
Published in: Familial Cancer 4/2009

01-12-2009

First case report of Muir–Torre syndrome associated with non-small cell lung cancer

Authors: L. Nolan, D. Eccles, E. Cross, G. Crawford, N. Beck, A. Bateman, C. Ottensmeier

Published in: Familial Cancer | Issue 4/2009

Login to get access

Abstract

The eponymous Muir–Torre syndrome (MTS) is a clinical variant of hereditary non polyposis colorectal cancer, and is defined as an autosomal dominant condition with simultaneous sebaceous neoplasms of the skin and visceral malignant disease resulting from germline mutations in the DNA mismatch repair (MMR) genes. To date the most common visceral malignancy described is colorectal cancer, which is seen in approximately 50% of cases. Other clearly associated tumours include endometrial adenocarcinomas, urothelial transitional cell carcinomas, upper gastrointestinal adenocarcinomas, sebaceous adenomas and ovarian (often mucinous) carcinomas. Here we report the first recorded case of adenocarcinoma of the lung with loss of MMR gene function to be identified in a patient with MTS. The MMR deficient lung tumour demonstrated less aggressive clinical behaviour compared with a synchronous MMR proficient lung adenocarcinoma.
Literature
7.
go back to reference Bakker PM, Tjon AJSS (1971) Multiple sebaceous gland tumours, with multiple tumours of internal organs. A new syndrome? Dermatologica 142(1):50–57CrossRefPubMed Bakker PM, Tjon AJSS (1971) Multiple sebaceous gland tumours, with multiple tumours of internal organs. A new syndrome? Dermatologica 142(1):50–57CrossRefPubMed
8.
go back to reference Reiffers J, Laugier P, Hunziker N (1976) Sebaceous hyperplasias, kerato-acanthomas, epitheliomas of the face and cancer of the colon. A new entity? Dermatologica 153(1):23–33PubMedCrossRef Reiffers J, Laugier P, Hunziker N (1976) Sebaceous hyperplasias, kerato-acanthomas, epitheliomas of the face and cancer of the colon. A new entity? Dermatologica 153(1):23–33PubMedCrossRef
13.
go back to reference Loukola A et al (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61(11):4545–4549PubMed Loukola A et al (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61(11):4545–4549PubMed
14.
go back to reference Lynch HT et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549PubMed Lynch HT et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549PubMed
15.
go back to reference Pineda M et al (2008) Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene. Genes Chromosomes Cancer 47:326–332CrossRefPubMed Pineda M et al (2008) Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene. Genes Chromosomes Cancer 47:326–332CrossRefPubMed
16.
go back to reference Lowsky R et al (1997) Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood 89(7):2276–2282PubMed Lowsky R et al (1997) Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood 89(7):2276–2282PubMed
17.
go back to reference Lowsky R et al (2000) MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood 95(5):1767–1772PubMed Lowsky R et al (2000) MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood 95(5):1767–1772PubMed
19.
go back to reference Xinarianos G et al (2000) hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res 60(15):4216–4221PubMed Xinarianos G et al (2000) hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res 60(15):4216–4221PubMed
Metadata
Title
First case report of Muir–Torre syndrome associated with non-small cell lung cancer
Authors
L. Nolan
D. Eccles
E. Cross
G. Crawford
N. Beck
A. Bateman
C. Ottensmeier
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 4/2009
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-009-9247-7

Other articles of this Issue 4/2009

Familial Cancer 4/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine